Skip to main content
Caplight Logo









Q'Apel Medical

Q'Apel Medical

Private
Fremont, CaliforniaHealthcare & Life Scienceshttps://qapelmedical.com/

Last Round

VC Round

May 9, 2024

Est. Valuation

$120.95M

Total Funding Raised

$67M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Q'Apel Medical is a medical devices company that develops and commercializes novel access device technology for neurovascular interventions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

neurovascular interventionballoon guide cathetermechanical thrombectomyaspiration catheterstroke interventionneurointerventional deviceneurovascular accessmedtechinterventional neuroradiologycatheterization labneurovascular toolsmedical device manufacturer

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Q'Apel Medical Comparables

Compare Q'Apel Medical with similar companies based on industry and business-model similarity.

Q'Apel Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Rapid Medical
89%
MIVI Neuroscience
89%
Route 92 Medical
87%

Q'Apel Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMay 9, 2024
Series DMay 11, 2022
Series CFeb 11, 2021

Key People

Founding team and executive leadership

Stewart Strong

Chief Executive Officer

Executive Team

Jeff Krolik

Chief Technology Officer

Executive Team

Ken Peartree

COO

Executive Team

Q'Apel Medical Investors

Notable investors and investment history

Q'Apel Medical investors
InvestorRounds
Soleus CapitalSeries D, Series C
Research Corporation TechnologiesSeries C, Series D
Cormorant Asset ManagementSeries D
RC CapitalSeries D, Series C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 67% MoM, reaching 5.2K.

  • Jun 20, 2026

    Monthly visitors increased 83% MoM.

Q'Apel Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Q'Apel Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Q'Apel Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersFremont, California
Employee Range117
Year Founded2016
Last FundingMay 9, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?